Diabetes Health Professional
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Top Rated

Related Community Videos on Diabetes Health TV

Surgeon's Skin Secret

Jim Kaiser

Surgeon's Skin Secret

Finding A Diabetes Educator Near You

Kim Higgins, CDE, RN

Finding A Diabetes Educator Near You

Author Dispels Diabetes Myths

Riva Greenberg

Author Dispels Diabetes Myths

Diabetes Health Reference Charts
Professional Issues Archives

Professional Diabetes Issues

Page 4
Resolvins, Discovered in Omega-3 Fatty Acids, Show Ability to Restore Lost Gum Disease Tissue and Bone

Dental researchers are reporting that resolvins, products derived from omega-3 fatty acids, may have the ability to restore the soft tissue and even bone lost in periodontal (gum) disease.

Comments 0 comments - May 7, 2009 - * * * * *

Common Glucose-Control Drug May Delay or Even Prevent Onset of Type 2

Voglibose*, a generic drug often used in combination with sulfonylureas to control blood glucose levels, appears to delay or even prevent the onset of diabetes in people who are predisposed to the disease.

Comments 6 comments - May 1, 2009 - * * * * *

Attention Healthcare Professionals: Grants Available for Integrating Patient-Recorded Observations into Clinical Care Processes

The Robert Wood Johnson Foundation (RWJF) has issued a call for proposals through its national program, Project HealthDesign: Rethinking the Power and Potential of Personal Health Records. Grant recipients will work to assess and test the potential of "observations of daily living" (ODLs) to help patients and physicians better manage chronic illnesses. 

Comments 0 comments - May 1, 2009 - * * * * *

Medtronic Jumps in to Help Deltec Pump Users

When Smiths Medical announced in late March that it was discontinuing the manufacture and sales of its Deltec Cozmo insulin pumps, the company's annual sales of that product were about $36 million. In contrast, Medtronic, manufacturer of the Minimed line of insulin pumps reported sales of $727 million in the nine months from April 2008 to January 2009.

Comments 8 comments - Apr 29, 2009 - * * * * *

Connect with Diabetes Health on Facebook and More!

Diabetes Health has joined the social networking sphere. Join us as a fan on Facebook, talk to us on Twitter, and subscribe to our RSS feed. Publisher and Editor-in-Chief, Nadia Al-Samarrie wants to hear your thoughts and she'll be reading what you have to say with great interest.

Comments 1 comment - Apr 28, 2009 - * * * * *

Long-Acting Byetta Tops Two Other Diabetes Drugs in Direct Comparison

Results from DURATION-2, a 26-week test comparing the diabetic drugs Januvia, Actos, and experimental long-acting Byetta (Byetta LAR) show that Byetta produced lower A1c's and more weight loss than the other two drugs.

Comments 5 comments - Apr 15, 2009 - * * * * *

Altea Partners With Amylin and Lilly to Develop 12-Hour Byetta Skin Patch

Buoyed by its recent successful phase 1 human clinical trial of a patch that delivers basal insulin through the skin, Atlanta-based Altea Therapeutics says it will work with Eli Lilly and Company and Amylin Pharmaceuticals, Inc., to develop a daily transdermal patch that deliver sustained levels of Byetta (exenatide). The patch, in a 12- and a 24-hour form, will use the company's proprietary PassPort Transdermal Delivery System. Lilly and Amylin will fund all development, manufacturing, and marketing activities for the product. 

Comments 2 comments - Apr 7, 2009 - * * * * *

Is the FDA Helping or Hurting Us When It Comes to New Medicines?

A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration's performance and concludes that the agency is over-funded, over-staffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan's Drug Problem: The Federal Monopoly of Pharmaceutical Regulation and Its Deadly Cost was authored by John R. Graham, Director of Health Care Studies at PRI. 

Comments 5 comments - Apr 7, 2009 - * * * * *

Tobacco as Medicine?

Last week we published an article about how the CDC says too many people are still smoking. The federal government has a Healthy People 2010 goal of reducing adult smoking rates to 12 percent or less by 2010. Of the 50 states, only Utah has thus far achieved that goal. 

Comments 1 comment - Apr 2, 2009 - * * * * *

Cells That “Think” They’re Not Consuming Glucose May Hold a Key to Longer Lifespan

Canadian scientists studying the effects of glucose on cellular aging have discovered an unusual effect that could change how doctors treat diabetes and even address the human lifespan. 

Comments 2 comments - Apr 1, 2009 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.